[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Mavyret- Drug Insight, 2019

July 2019 | 35 pages | ID: M49978EE455EN
DelveInsight

US$ 1,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 48 Hours

'Mavyret - Drug Insight, 2019' report by DelveInsight provides comprehensive information of the drug, Mavyret. It includes drugs overview, Mavyret mechanism of action, clinical trials, regulatory milestones, deals & Mavyret’s partnerships. It further provides Mavyret`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted Mavyret sales till 2021. The report also throws light on Mavyret market competition and emerging therapies in the same space as Mavyret. Mavyret SWOT analysis is also featured. * Depending on information availability

METHODOLOGY

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

SCOPE OF THE REPORT
  • A comprehensive Mavyret overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Mavyret Patent information in United States (US) and Europe (EU) has been highlighted
  • Mavyret API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Mavyret sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Mavyret operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Mavyret SWOT analysis
REASONS TO BUY
  • Establish a comprehensive understanding of the drug, Mavyret
  • Access to Mavyret API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Mavyret patents for the major markets- US and EU
  • Understand current and future Mavyret`s growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Mavyret
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Mavyret
  • Identify opportunities in the same area as with Mavyret SWOT analysis
1. REPORT INTRODUCTION

2. MAVYRET - OVERVIEW

Mavyret Product Description
Mavyret Route of Synthesis
Mavyret Mechanism of Action
Mavyret Pharmacology
Mavyret Pharmacodynamics
Mavyret Pharmacokinetics
Mavyret Adverse Reactions
Mavyret Clinical Trials
Mavyret Regulatory Milestones
Mavyret Development Activities

3. GLOBAL API MANUFACTURERS

United States
Europe
China
India

4. PRODUCT DETAILS

United States
Europe

5. MAVYRET GLOBAL SALES ASSESSMENT

Mavyret Sales Global(Historical)
Mavyret Sales Global(Forecasted)

6. MAVYRET PATENT DETAILS

7. MAVYRET MARKET COMPETITION

8. MAVYRET EMERGING THERAPIES

8.1. Drug name: Company name
Product Description
Research & Development
Product Development Activities
Other product profiles in the detailed report

9. MAVYRET SWOT ANALYSIS

Appendix
Methodology
Consulting Services
About DelveInsight

LIST OF TABLES

Table 1: Mavyret, Description
Table 2: API Manufacturers Region wise
Table 3: API Manufacturers for United States
Table 4: API Manufacturers for Europe
Table 5: API Manufacturers for China
Table 6: API Manufacturers for India
Table 7: Mavyret Product Details, United States
Table 8: Mavyret Product Details, Europe
Table 9: Mavyret, Historical Global Sales till 2017 (in million USD)
Table 10: Mavyret, Forecasted Global Sales from 2019-2021 (in million USD)
Table 11: Patent Details: Mavyret
Table 12: Mavyret Major Competitors
Table 13: Emerging Therapies

LIST OF FIGURES

Figure 1: Mavyret
Figure 2: Mavyret, Historical Global Sales till 2017 (in million USD)
Figure 3: Mavyret, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 4: Patent Details: Mavyret
Figure 5: API Manufacturers Region wise


More Publications